+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Epigenetics Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments, Enzymes, Services), By Application (Oncology, Non-oncology), By Technology, By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 150 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5846777
Description Jump to:
The global epigenetics diagnostic market size is expected to reach USD 39.15 billion by 2030, expanding at a CAGR of 15.10% over the forecast period, according to a new study by the publisher. The growth is attributed to the rising incidence of major depressive disorder (MDD). According to WHO, in 2023, around 5% of adults suffer from depressive disorder. Furthermore, according to a study published by NCBI in 2022, around 280 million people are affected by MDD across the globe. Additionally, technological advancement in the field of epigenetic drug discovery is also contributing to the growth. A study published by BioMed Central Ltd. states that there is an increasing inclination towards selective isoform inhibitor construction to produce anti-tumor effects.

Moreover, increasing investment from public and private organizations in the field of epigenetics is anticipated to drive the market during 2023-2030. For instance, in March 2023, Chroma Medicine, Inc., a leader in single-dose epigenetic editing systems, completed a USD 135 million Series B funding. The financing was led by Google Ventures for the advancement in the field of epigenetic editing technology.

Key players in the industry are adopting various strategies to strengthen their market position and expand their customer base. For instance, in May 2022, Cardio Diagnostics, Inc., and Mana Capital Acquisition Corp. entered a business agreement. The goal of this agreement was to create a publicly listed company to transform cardiovascular disease through the application of epigenetics. Moreover, in February 2022, Element Bioscience, Inc., and Dovetail Genomics announced a partnership to demonstrate the performance and value of Dovetail’s next-generation sequencing library prep service on Element’s AVITI system.

The COVID-19 pandemic has positively impacted the market by creating opportunities for epigenetics researchers to study the impact of the COVID-19 virus on DNA methylation changes and myeloid differentiation. A study published by NCBI in 2022 states that epigenetic modification not only plays a crucial role in the maintenance of cellular homeostasis and the genome but also provides information about the cause and development of virus infection.

Epigenetics Diagnostics Market Report Highlights

  • Based on product, the reagent segment dominated the market with a share of 31.50% in 2022. The growth is attributed to the rising demand for reagents in epigenetic research studies.
  • Based on technology, the DNA methylation segment accounted for the largest revenue share of 46.73% in 2022, owing to its increasing demand in chronic disease treatment.
  • Based on application, the oncology application segment accounted for the largest revenue share of 69.23% in 2022. The segment growth is attributed to the increasing demand for epigenetics research in the field of cancer owing to its growing incidences.
  • North America dominated the market with a revenue share of 38.18% in 2022, owing to the presence of prominent market players and technologically advanced healthcare infrastructure. Moreover, rising awareness coupled with high R&D expenditure is anticipated to drive growth over the forecast period.
  • Some of the major players in the market are Roche Diagnostics, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., Novartis AG, Element Biosciences, Inc., Dovetail Genomics LLC., Illumina, Inc., ValiRx Plc., and Abcam plc.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Epigenetics Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer
3.2.1.2. Rise in number of geriatric patients
3.2.1.3. Expanding governmental initiatives in the epigenetics field
3.2.2. Market restraint analysis
3.2.2.1. Worries about diagnoses using epigenetics in terms of standardization
3.2.2.2. Lack of skilled professionals
3.2.3. Market opportunity analysis
3.2.3.1. Improvement in healthcare infrastructure in developing economies
3.3. Epigenetics Diagnostics Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Epigenetics Diagnostics Market: Product Movement Analysis
4.2. Reagents
4.2.1. Reagents Market, 2018 - 2030 (USD Million)
4.3. Kits
4.3.1. Kits Market, 2018 - 2030 (USD Million)
4.3.2. Chip Sequencing Kit
4.3.2.1. Chip sequencing kit Market, 2018 - 2030 (USD Million)
4.3.3. Whole Genomic Amplification kit
4.3.3.1. Whole Genomic Amplification Kit Market, 2018 - 2030 (USD Million)
4.3.4. Bisulfite Conversion Kit
4.3.4.1. Bisulfite Conversion Kit Market, 2018 - 2030 (USD Million)
4.3.5. RNA Sequencing Kit
4.3.5.1. RNA Sequencing Kit Market, 2018 - 2030 (USD Million)
4.3.6. Others
4.3.6.1. Others Market, 2018 - 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments Market, 2018 - 2030 (USD Million)
4.5. Enzymes
4.5.1. Enzymes Market, 2018 - 2030 (USD Million)
4.6. Services
4.6.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Epigenetics Diagnostics Market: Application Movement Analysis
5.2. Oncology
5.2.1. Oncology Market, 2018 - 2030 (USD Million)
5.2.2. Solid Tumors
5.2.2.1. Solid Tumors Market, 2018 - 2030 (USD Million)
5.2.3. Others
5.2.3.1. Others Market, 2018 - 2030 (USD Million)
5.3. Non-oncology
5.3.1. Non-oncology Market, 2018 - 2030 (USD Million)
5.3.2. Inflammatory Diseases
5.3.2.1. Inflammatory Diseases Market, 2018 - 2030 (USD Million)
5.3.3. Metabolic Diseases
5.3.3.1. Metabolic Diseases Market, 2018 - 2030 (USD Million)
5.3.4. Infectious Diseases
5.3.4.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
5.3.5. Cardiovascular Diseases
5.3.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
5.3.6. Others
5.3.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Technology Business Analysis
6.1. Epigenetics Diagnostics Market: Technology Movement Analysis
6.2. DNA Methylation
6.2.1. DNA Methylation Market, 2018 - 2030 (USD Million)
6.3. Histone Methylation
6.3.1. Histone Methylation Market, 2018 - 2030 (USD Million)
6.4. Histone Acetylation
6.4.1. Histone Acetylation Market, 2018 - 2030 (USD Million)
6.5. Large noncoding RNA
6.5.1. Large noncoding RNA Market, 2018 - 2030 (USD Million)
6.6. MicroRNA modification
6.6.1. MicroRNA modification Market, 2018 - 2030 (USD Million)
6.7.1. Chromatin Structure Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Epigenetics Diagnostics Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. U.S. Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Reimbursement Scenario
7.2.4.6. Canada Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. UK Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. Germany Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. France Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Italy Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Spain Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Denmark Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Sweden Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Reimbursement Scenario
7.3.10.6. Norway Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. Japan Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. China Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. India Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. Australia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Thailand Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Reimbursement Scenario
7.4.8.6. South Korea Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Brazil Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Mexico Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Reimbursement Scenario
7.5.5.6. Argentina Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. South Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. Saudi Arabia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. UAE Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Reimbursement Scenario
7.6.6.6. Kuwait Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Roche Diagnostics
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Type benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Thermo Fisher Scientific, Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Type benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Eisai Co. Ltd.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Type benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Novartis AG
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Type benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Element Biosciences, Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Type benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Dovetail Genomics LLC.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Type benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Illumina, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Type benchmarking
8.4.7.4. Strategic initiatives
8.4.8. ValiRx Plc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Type benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Abcam plc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Type benchmarking
8.4.9.4. Strategic initiatives
List of Tables
Table 1: List of Abbreviation
Table 2: North America Epigenetics diagnostics market, by country, 2018-2030 (USD Million)
Table 3: North America Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 4: North America Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 5: North America Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 6: U.S. Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 7: U.S. Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 8: U.S. Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 9: Canada Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 10: Canada Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 11: Canada Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 12: Europe Epigenetics diagnostics market, by country, 2018-2030 (USD Million)
Table 13: Europe Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 14: Europe Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 15: Europe Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 16: UK Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 17: UK Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 18: UK Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 19: Germany Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 20: Germany Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 21: Germany Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 22: France Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 23: France Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 24: France Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 25: Italy Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 26: Italy Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 27: Italy Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 28: Spain Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 29: Spain Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 30: Spain Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 31: Denmark Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 32: Denmark Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 33: Denmark Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 34: Sweden Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 35: Sweden Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 36: Sweden Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 37: Norway Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 38: Norway Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 39: Norway Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 40: Asia Pacific Epigenetics diagnostics market, by country, 2018-2030 (USD Million)
Table 41: Asia Pacific Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 42: Asia Pacific Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 43: Asia Pacific Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 44: China Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 45: China Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 46: China Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 47: Japan Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 48: Japan Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 49: Japan Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 50: India Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 51: India Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 52: India Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 53: Australia Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 54: Australia Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 55: Australia Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 56: South Korea Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 57: South Korea Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 58: South Korea Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 59: Thailand Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 60: Thailand Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 61: Thailand Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 62: Latin America Epigenetics diagnostics market, by country, 2018-2030 (USD Million)
Table 63: Latin America Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 64: Latin America Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 65: Latin America Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 66: Brazil Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 67: Brazil Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 68: Brazil Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 69: Mexico Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 70: Mexico Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 71: Mexico Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 72: Argentina Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 73: Argentina Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 74: Argentina Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 75: Middle East and Africa Epigenetics diagnostics market, by country, 2018-2030 (USD Million)
Table 76: Middle East and Africa Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 77: Middle East and Africa Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 78: Middle East and Africa Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 79: South Africa Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 80: South Africa Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 81: South Africa Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 82: Saudi Arabia Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 83: Saudi Arabia Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 84: Saudi Arabia Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 85: UAE Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 86: UAE Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 87: UAE Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
Table 88: Kuwait Epigenetics diagnostics market, by product, 2018-2030 (USD Million)
Table 89: Kuwait Epigenetics diagnostics market, by application, 2018-2030 (USD Million)
Table 90: Kuwait Epigenetics diagnostics market, by technology, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market Research Process
Fig. 2: Information Procurement
Fig. 3: Primary Research Pattern
Fig. 4: Market Research Approaches
Fig. 5: Value Chain-Based Sizing & Forecasting
Fig. 6: Market Formulation & Validation
Fig. 7: Epigenetics Diagnostics Market Segmentation
Fig. 8: Market Snapshot, 2022
Fig. 9: Market Trends & Outlook
Fig. 10: Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11: Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12: PESTEL Analysis
Fig. 13: Porter’s Five Forces Analysis
Fig. 14: Global Epigenetics Diagnostics Market: Product Key Takeaways
Fig. 15: Global Epigenetics Diagnostics Market: Product Movement Analysis
Fig. 16: Global Epigenetics Diagnostics Market, For Reagents, 2018-2030 (USD Million)
Fig. 17: Global Epigenetics Diagnostics Market, For Kits, 2018-2030 (USD Million)
Fig. 18: Global Epigenetics Diagnostics Market, For Instruments, 2018-2030 (USD Million)
Fig. 19: Global Epigenetics Diagnostics Market, For Enzymes, 2018-2030 (USD Million)
Fig. 20: Global Epigenetics Diagnostics Market, For Services, 2018-2030 (USD Million)
Fig. 21: Global Epigenetics Diagnostics Market: Application Key Takeaways
Fig. 22: Global Epigenetics Diagnostics Market: Application Movement Analysis
Fig. 23: Global Epigenetics Diagnostics Market, For Oncology, 2018-2030 (USD Million)
Fig. 24: Global Epigenetics Diagnostics Market, For Non-oncology, 2018-2030 (USD Million)
Fig. 25: Global Epigenetics Diagnostics Market: Technology Key Takeaways
Fig. 26: Global Epigenetics Diagnostics Market: Technology Movement Analysis
Fig. 27: Global Epigenetics Diagnostics Market, For DNA Methylation, 2018-2030 (USD Million)
Fig. 28: Global Epigenetics Diagnostics Market, For Histone Methylation, 2018-2030 (USD Million)
Fig. 29: Global Epigenetics Diagnostics Market, For Histone Acetylation, 2018-2030 (USD Million)
Fig. 30: Global Epigenetics Diagnostics Market, For Large noncoding RNA, 2018-2030 (USD Million)
Fig. 31: Global Epigenetics Diagnostics Market, For MicroRNA modification, 2018-2030 (USD Million)
Fig. 32: Global Epigenetics Diagnostics Market, For Chromatin Structure, 2018-2030 (USD Million)
Fig. 33: Regional Marketplace: Key Takeaways
Fig. 34: Regional Outlook, 2022 & 2030
Fig. 35: Global Epigenetics Diagnostics Market: Region Movement Analysis
Fig. 36: North America Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 37: U.S. Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 38: Canada Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 39: Europe Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 40: Germany Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 41: UK Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 42: France Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 43: Italy Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 44: Spain Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 45: Denmark Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 46: Sweden Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 47: Norway Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 48: Asia Pacific Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 49: Japan Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 50: China Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 51: India Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 52: Australia Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 53: South Korea Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 54: Thailand Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 55: Latin America Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 56: Brazil Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 57: Mexico Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 58: Argentina Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 59: Middle East And Africa Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 60: South Africa Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 61: Saudi Arabia Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 62: UAE Epigenetics Diagnostics Market, 2018-2030 (USD Million)
Fig. 63: Kuwait Epigenetics Diagnostics Market, 2018-2030 (USD Million)

Companies Mentioned

  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Eisai Co. Ltd.
  • Novartis AG
  • Element Biosciences, Inc.
  • Dovetail Genomics LLC.
  • Illumina, Inc.
  • ValiRx Plc.
  • Abcam plc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 12.82 Billion
Forecasted Market Value ( USD ) by 2030 $ 39.15 Billion
Compound Annual Growth Rate15.1%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits), By Application (Oncology, Non-oncology), By Technology (MicroRNA Modification, Chromatin Structures), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits), By Application (Oncology, Non-oncology), By Technology (MicroRNA Modification, Chromatin Structures), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Global Epigenetics Market by Product (Enzymes, Instruments & Accessories, Reagents & Kits), Technique (Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction), Methods, Application, End User - Forecast 2023-2030 - Product Image

Global Epigenetics Market by Product (Enzymes, Instruments & Accessories, Reagents & Kits), Technique (Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction), Methods, Application, End User - Forecast 2023-2030

  • Report
  • 185 Pages
  • Global
From
Epigenetic Drug and Diagnostic Technology Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Epigenetic Drug and Diagnostic Technology Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Epigenetics Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Epigenetics Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 190 Pages
  • Global
From
Global Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology), and Region - Forecast to 2028 - Product Image

Global Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology), and Region - Forecast to 2028

  • Report
  • 353 Pages
  • Global
From

About the Epigenetic Diagnostics Market

The Epigenetic Diagnostics market is a subset of the larger Genomics market. It focuses on the study of epigenetic changes, which are modifications to the genome that do not involve changes to the underlying DNA sequence. These changes can be used to diagnose and treat a variety of diseases, including cancer, neurological disorders, and autoimmune diseases. Epigenetic diagnostics can also be used to identify individuals at risk for certain diseases, allowing for earlier intervention and better outcomes. Epigenetic diagnostics is a rapidly growing field, with a wide range of applications. Companies in the market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and Oxford Nanopore Technologies. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.